The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options, PDMR Shareholding & TVR

29 May 2019 15:06

RNS Number : 5112A
Surgical Innovations Group PLC
29 May 2019
 

 

Surgical Innovations Group plc

("SI Group" or "the Company")

 

Exercise of Options, PDMR Shareholding & Total Voting Rights

 

 

Exercise of Options

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that, on 24 May 2019, it issued and allotted a total of 1,500,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by an employee of the Company.

PDMR Shareholding

The Company announces that, also on 24 May 2019, it issued and allotted a total of 1,500,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by Charmaine Day, Company Secretary and PDMR. As part of this transaction, Mrs Day sold 1,000,000 shares at a price of 4 pence per share.

 

Following this transaction, the beneficial holding of Charmaine Day in the Company is 805,343 shares, representing approximately 0.1% of the issued share capital.

 

Application will be made to the London Stock Exchange for admission of the 3,000,000 ordinary shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 4 June 2019.

 

Total Voting Rights

Following Admission, the Company will have 790,566,177 ordinary Shares in issue with each share carrying the right to one vote. The Company has no ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 790,566,177.

 

 

 

For further information please contact:

 

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Non-Executive Chairman

Tel: 0113 230 7597

Melanie Ross, Chief Financial Officer

N+1 Singer (Nominated Advisor and Broker)

Tel: 020 7496 3000

Richard Lindley

Rachel Hayes

Walbrook PR (Financial PR & Investor Relations)

Tel: 020 7933 8780 or si@walbrookpr.com

Paul McManus

Mob: 07980 541 893

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Charmaine Day

2

Reason for the notification

a)

Position/status

Company Secretary, Surgical Innovations Group plc

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1p

 

 

 

GB0004016704

b)

Nature of the transactions

Exercise of 1,500,000 share options ("Exercise")

Sale of 1,000,000 Ordinary Shares of 1p ("Sale")

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

 

 

 

In relation to the Exercise:

1.575p

 

In relation to the Sale:

4p

 

1,500,000

 

 

1,000,000

 

 

 

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

Not applicable, the Exercise and the Sale were each completed as single transactions

 

 

completed as

e)

Date of the transactions

 24 May 2019

 

f)

Place of the transactions

In respect of the Exercise, outside a trading venue

In respect of the Sale, London Stock Exchange, AIM Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFISESIAFIA
Date   Source Headline
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSNotice of Interim Results
27th Jun 20223:15 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Trading Statement
25th May 20227:00 amRNSPosting of 2021 Annual Report & Accounts
9th May 202212:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSFinal Results
21st Mar 20227:00 amRNSProduct launch in partnership with CMR Surgical
10th Mar 20227:00 amRNSNotice of Annual Results
17th Jan 20227:00 amRNSYear-end Trading Update
15th Nov 20217:00 amRNSChanges to Board Structure & CFO Appointment
10th Nov 20215:43 pmRNSGrant of Options
15th Sep 20217:00 amRNSHalf-year Report
27th Aug 20217:00 amRNSNotice of Interim Results
9th Jul 20212:29 pmRNSDirector/PDMR Shareholding
22nd Jun 20215:26 pmRNSResult of AGM
22nd Jun 20217:00 amRNSAGM Trading Statement
21st Jun 20217:00 amRNSWithdrawal of AGM Resolution
21st May 20217:00 amRNSPosting of Annual Report& Accounts & Notice of AGM
25th Mar 20217:00 amRNSFinal Results
22nd Mar 20217:00 amRNS3-year Exclusive UK distribution agreement
8th Mar 20217:00 amRNSNotice of annual results
15th Feb 20217:00 amRNS5-year USA distribution agreement
9th Feb 20217:00 amRNSLaunch of the Green Surgery Challenge
8th Jan 20217:00 amRNSDistalmotion’s Dexter Robot receives CE Mark
7th Jan 20217:00 amRNSFuture board change
21st Dec 20207:00 amRNSTrading update
17th Dec 20207:00 amRNSUS distribution agreement signed with Adler
7th Dec 20203:00 pmRNSReplacement of Auditor
2nd Dec 20207:00 amRNSProduct launch for Cellis Breast
25th Nov 20207:00 amRNSCentre for Sustainable Healthcare collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.